<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="40076">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01763723</url>
  </required_header>
  <id_info>
    <org_study_id>H-1-2012-025</org_study_id>
    <nct_id>NCT01763723</nct_id>
  </id_info>
  <brief_title>Pigment-Tan-Safety Study of a Light-based Home Device for Hair Removal in Adult Subjects</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bispebjerg Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bispebjerg Hospital</source>
  <oversight_info>
    <authority>Denmark: The Danish National Committee on Biomedical Research Ethics</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      This studies was designed to investigate the importance of skin type and UV-exposure on side
      effects after exposure to an Intense Pulsed Light Home-use device.

      21 healthy subjects will receive 8 UV-exposures on one buttock and subsequently three weekly
      IPL-exposures.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Twenty-one healthy subjects will be exposed to UV-exposures 8 times over 3 weeks on a
      test-area (4 x 6cm) on one buttock to induce pigmentation. This will be followed by 3 weekly
      IPL (intense pulsed light) exposures. At 24 hours after the first IPL exposure, biopsies
      will be excised from the buttocks of the subjects (4 each).The skin will be evaluated after
      IPL exposure for: skin reactions, pain and mRNA expression of two pigment markers. Follow-up
      visits is planned at 1 and 4 weeks after the third and final IPL exposure.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>April 2012</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Changes in skin reaction development</measure>
    <time_frame>Immediately after, 1 hr after, 16-24 hrs after, 1 week and 4 weeks after IPL exposure</time_frame>
    <safety_issue>Yes</safety_issue>
    <description>Redness, edema, pigment changes, texture changes, blisters and crusting</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>Immediately after IPL exposure (approx. 2 min)</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>mRNA expression of pigment markers</measure>
    <time_frame>16-24 hrs after the first IPL exposure</time_frame>
    <safety_issue>Yes</safety_issue>
  </other_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">21</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>IPL after UV-exposure</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 UV-exposures followed by 3 weekly IPL exposures</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IPL-home use device</intervention_name>
    <description>A light based home use device for hair removal</description>
    <arm_group_label>IPL after UV-exposure</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy, over 18 years, no childbearing potential, signed informed consent, no
             moles,tattoos, freckles or scars in the test-area, skin type II-IV

        Exclusion Criteria:

          -  disease in test-area, prior treatment to IPL, taking drugs interfering with the
             immune system
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bispebjerg Hospital</name>
      <address>
        <city>Copenhagen</city>
        <state>Bispebjerg</state>
        <zip>2400</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>January 8, 2013</lastchanged_date>
  <firstreceived_date>December 20, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bispebjerg Hospital</investigator_affiliation>
    <investigator_full_name>Christina Haak</investigator_full_name>
    <investigator_title>MD.</investigator_title>
  </responsible_party>
  <keyword>Intense pulsed light,</keyword>
  <keyword>UV-exposure,</keyword>
  <keyword>skin type,</keyword>
  <keyword>safety,</keyword>
  <keyword>pigment,</keyword>
  <keyword>home-use</keyword>
  <keyword>subjects</keyword>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
